English | Español

Regulatory
+ Regulatory
John Breslin | Apr 25, 2017

Health trends worsened under Obamacare, study says
+ Regulatory
Caitlin Nordahl | Apr 25, 2017

Cancer advocates urge Vermont lawmakers to raise age to buy tobacco to 21
+ Regulatory
Caitlin Nordahl | Apr 24, 2017

BioMarin, Par reach settlement on Kuvan
+ Regulatory
Marian Johns | Apr 23, 2017

FDA issues complete response letter for Merck's diabetes drug labeling
+ Regulatory
Caitlin Nordahl | Apr 22, 2017

New RA research shows value of biologic treatments greater than initial assessments
+ Regulatory
Caitlin Nordahl | Apr 22, 2017

ACS CAN criticizes new CMS rule for potential negative effects on cancer patients, survivors
+ Regulatory
John Breslin | Apr 22, 2017

Republicans consider adding reinsurance program to health care plan
+ Regulatory
Robert Hadley | Apr 21, 2017

Funding cuts to New Mexico cancer center triggers outcry

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes